Mumbai, Maharashtra, India, February 2026 — Macleods Pharmaceuticals Ltd. has appointed Mr. Ashok Kumar Prasad as its Chief Financial Officer (CFO). He has assumed the role in February 2026 and will be based in Mumbai.
As CFO, Prasad will lead the company’s financial strategy, governance, capital allocation, and performance management, supporting Macleods’ continued expansion as a vertically integrated global pharmaceutical organization.
Prior to joining Macleods Pharmaceuticals Ltd., Prasad served as President – Finance at PI Industries Ltd, where he was responsible for strategic financial planning and driving business transformation initiatives.
Earlier, he held leadership roles at Adani Ports and SEZ, including Merger Acquisition (M&A) and Business Development Lead, and Head Finance – Adani Logistic Ltd, where he led growth strategy, expansion initiatives (greenfield and brownfield), process automation, and instilled strong financial discipline across operations.
Before Adani Group, Prasad spent nearly seven years at Mondelēz International, serving as Finance Controller (Corporate Accounting & Reporting and Cash Flow Management) and in various supply chain and contract manufacturing finance leadership roles. He led controllership responsibilities for India and Bangladesh entities, managed IFRS and US GAAP reporting, strengthened internal controls, and drove working capital optimization.
Earlier in his career, he held key finance leadership positions at Jindal Steel & Power Ltd., Ford Motor Company, and Tata Motors, driving P&L management, product costing, FP&A, taxation, budgeting, and operational efficiency initiatives across domestic and international markets.
With extensive experience across pharmaceuticals, logistics, FMCG, automotive, and infrastructure sectors, Prasad brings strong expertise in strategic planning, financial governance, business analytics, digital transformation, and M&A to Macleods Pharmaceuticals.
About Macleods Pharmaceuticals Ltd.
Macleods Pharmaceuticals Ltd. is a vertically integrated global pharmaceutical company established in 1989. The company develops, manufactures, and markets a wide range of formulations across major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatments.
With a diversified portfolio spanning solid and liquid orals, topical formulations, injectables, and inhalers, Macleods is committed to delivering high-quality, affordable, and innovative medicines worldwide.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
